NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...
Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...
Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Nov 11 (Reuters) - Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, on Wednesday said it would be challenging to distribute vaccines that use messenger RNA ...
Researchers at the University of Pennsylvania and Cincinnati Children’s Hospital have developed a novel mRNA vaccine that ...
Settlement reached over mRNA-based COVID vaccines CureVac and GSK get $740 million upfront, and royalties BioNTech's deal to buy CureVac on track GSK's own lawsuits against Pfizer, BioNTech unaffected ...
New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune ...
A newly developed vaccine that was found to prevent dangerous immune reactions and life-threatening inflammation in mice could lead to a cure for deadly allergies in humans. At such a critical moment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback